News

AddToAny

Google+ Facebook Twitter Twitter

Preventing allergic reactions

Researchers have discovered a new mechanism in which an antibody can prevent allergic reactions in a broad range of patients.

The team at the Aarhus University in Denmark was intending to find new methods to improve existing treatment for allergies, but instead came across an antibody that apparently operates
in a unique way to block the immune effect and inactivate the allergic process when it is triggered.

The antibody interacts in a complex biochemical process in the human body and prevents the human allergy antibody (IgE) from attaching to cells, so stopping any allergic symptoms.

Edzard Spillner, one of the study authors, said: “We can now describe the interaction of this antibody with its target and the conformational changes very accurately. 

“This allows us to understand how it interferes with the IgE and its specific receptors on the immune cells of the body, which are responsible for releasing histamine in an allergic reaction.” 

A complete paper on the work was published online in January by the journal Nature Communication.

go.nature.com/2EmtIIq

Related Articles

neutrophil cell trapping bacteria Image Credit | Science Photo Library-p2760184

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

Tuberculosis vaccine bacteria-Image Credit | Science Photo Library - b2201433

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.

genetics mutations cancer - CREDIT - alamy-2jkftm9

The evolution of cancer

Charlie Swanton outlines the work in cancer research that led to him being awarded a 2024 Louis-Jeantet Prize for translational medicine.

A nurse takes the blood pressures of a woman as she waits with an infant at Ndirande Health Centre in Blantyre on February 21, 2018 - Image credit - Getty-922184246

Vaccine effective in preventing typhoid fever

A single dose of the typhoid conjugate vaccine Typbar TCV provides lasting efficacy in preventing typhoid fever in children aged nine months to 12 years old, according to a new study.

Top